7:15 am - Registration & Networking
8 am - Breakfast & Program

In an unprecedented time of market challenges, life sciences industry leaders and investors alike are searching for answers on how to secure critical partnering agreements or needed funding.   As part of ongoing programming to bring together industry and capital, MAVA is hosting this special event for the greater healthcare and biotechnolgy business and investor communities.
 
MAVA is proud to present NEA General Partner David Mott as its keynote speaker at this year’s Fall Vanguard Forum. Given Mott's active involvement on numerous company boards, coupled with his past operations experience as President and CEO of MedImmune (acquired by AstraZeneca), Mott is uniquely positioned to offer his perspective on the changing marketplace and the latest trends in creating successful strategic partnerships.
 
Don't miss this valuable opportunity for life sciences investors and their portfolio companies' CEO/CXOs and key professionals who partner in developing companies from our region to hear this expert's opinions.  We hope that you can attend and encourage you to forward this invitation to your colleagues as well.